5-ethynyl-1-ribofuranosylimidazole-4-carboxamide has been researched along with inosinic acid in 2 studies
| Studies (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Trials (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Recent Studies (post-2010) (5-ethynyl-1-ribofuranosylimidazole-4-carboxamide) | Studies (inosinic acid) | Trials (inosinic acid) | Recent Studies (post-2010) (inosinic acid) |
|---|---|---|---|---|---|
| 21 | 0 | 2 | 1,086 | 29 | 204 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; De Clercq, E | 1 |
| Balzarini, J; De Clercq, E; Lee, CK; Schols, D | 1 |
2 other study(ies) available for 5-ethynyl-1-ribofuranosylimidazole-4-carboxamide and inosinic acid
| Article | Year |
|---|---|
Assay method for monitoring the inhibitory effects of antimetabolites on the activity of inosinate dehydrogenase in intact human CEM lymphocytes.
Topics: Adenosine Triphosphate; Antimetabolites; Cell Line; Guanosine Triphosphate; Humans; Hypoxanthine; Hypoxanthines; IMP Dehydrogenase; Inosine; Inosine Monophosphate; Kinetics; Lymphocytes; Ribonucleosides | 1992 |
1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) and 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide (EICAR) markedly potentiate the inhibitory effect of 2',3'-dideoxyinosine on human immunodeficiency virus in peripheral blood lymph
Topics: Antiviral Agents; Cells, Cultured; Didanosine; Drug Synergism; Guanosine Diphosphate; Guanosine Monophosphate; Guanosine Triphosphate; HIV-1; Humans; Inosine Monophosphate; Kinetics; Lymphocytes; Ribavirin; Ribonucleosides | 1991 |